Galtier, J., Basile, G. and Bouabdallah, K. (2020) “Response to comment on: "Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience"”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301477.